{
    "nct_id": "NCT03579446",
    "official_title": "Levorphanol as a Second Line Opioid in Cancer Patients Undergoing Opioid Rotation: An Open Label Study",
    "inclusion_criteria": "* Patients seen in the SCC or Pain Clinic with a diagnosis of cancer with or without evidence of metastatic disease\n* Diagnosis of cancer related pain currently treated with first line strong oral opioid analgesics such as morphine, oxycodone, oxymorphone, hydromorphone or hydrocodone\n* Age 18 or older\n* Able to complete study assessments\n* Individual is willing to sign written informed consent\n* Patients who are classified as being opioid tolerant by receiving a baseline MEDD of >= 60 mg\n* Patients who are local and able to follow-up in the SCC or Pain Clinic within 30 days if necessary\n* Eastern Cooperative Oncology Group (ECOG) performance status of =< 3\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Cognitive impairment with a Memorial Delirium Assessment Scale (MDAS) score of 7 or higher or diagnosed with neurocognitive impairment by the treating SCC or Pain Clinic physician\n* Renal insufficiency defined as estimated glomerular filtration rate of < 60\n* Hepatic insufficiency defined as transaminitis (aspartate aminotransferase [AST] or alanine aminotransferase [ALT] > 3 times the highest normal value) or hyperbilirubinemia of > 1.5 times the highest normal value\n* Non-English speaking participants as not all assessments are validated in other languages\n* Presence of neuropathic pain as a primary pain syndrome\n* Non-malignant pain\n* Patients with history of alcohol or substance abuse by using Cut-down, Annoyed, Guilty, Eye-opener adapted to include Drug use questionnaire (CAGE-AID) score of 2 or higher; Pain Clinic: Screener and Opioid Assessment for Patients with Pain (SOAPP) score of 7 or higher. In the unlikely event that CAGE-AID or SOAPP is not present in patient's chart, a CAGE-AID questionnaire will be administered after obtaining verbal consent for screening\n* Patients receiving methadone due to reasons such as long and variable half-life\n* Patients receiving scheduled benzodiazepines due to the risk of excessive sedation\n* Patients with a MEDD of > 300\n* Unable or unwilling to sign consent",
    "miscellaneous_criteria": ""
}